ATC code C02: Difference between revisions
imported>Whywhenwhohow 2025 additions |
imported>Whywhenwhohow anchors; 2026 updates |
||
| Line 2: | Line 2: | ||
{{ATC codes lead|C|02|Antihypertensives}} | {{ATC codes lead|C|02|Antihypertensives}} | ||
== | ==<span class="anchor" id="C02A"></span>C02A Antiadrenergic agents, centrally acting== | ||
=== | ===<span class="anchor" id="C02AA"></span>C02AA Rauvolfia alkaloids=== | ||
:C02AA01 [[Rescinnamine]] | :C02AA01 [[Rescinnamine]] | ||
:C02AA02 [[Reserpine]] | :C02AA02 [[Reserpine]] | ||
| Line 16: | Line 16: | ||
:C02AA57 Bietaserpine, combinations | :C02AA57 Bietaserpine, combinations | ||
=== | ===<span class="anchor" id="C02AB"></span>C02AB Methyldopa=== | ||
:C02AB01 [[Methyldopa]] ([[levorotatory]]) | :C02AB01 [[Methyldopa]] ([[levorotatory]]) | ||
:C02AB02 Methyldopa ([[racemic]]) | :C02AB02 Methyldopa ([[racemic]]) | ||
=== | ===<span class="anchor" id="C02AC"></span>C02AC Imidazoline receptor agonists=== | ||
:C02AC01 [[Clonidine]] | :C02AC01 [[Clonidine]] | ||
:C02AC02 [[Guanfacine]] | :C02AC02 [[Guanfacine]] | ||
| Line 27: | Line 27: | ||
:C02AC06 [[Rilmenidine]] | :C02AC06 [[Rilmenidine]] | ||
== | ==<span class="anchor" id="C02B"></span>C02B Antiadrenergic agents, ganglion-blocking== | ||
=== | ===<span class="anchor" id="C02BA"></span>C02BA Sulfonium derivatives=== | ||
:C02BA01 [[Trimetaphan]] | :C02BA01 [[Trimetaphan]] | ||
=== | ===<span class="anchor" id="C02BB"></span>C02BB Secondary and tertiary amines=== | ||
:C02BB01 [[Mecamylamine]] | :C02BB01 [[Mecamylamine]] | ||
=== | ===<span class="anchor" id="C02BC"></span>C02BC Bisquaternary ammonium compounds=== | ||
== | ==<span class="anchor" id="C02C"></span>C02C Antiadrenergic agents, peripherally acting== | ||
=== | ===<span class="anchor" id="C02CA"></span>C02CA Alpha-adrenoreceptor antagonists=== | ||
:C02CA01 [[Prazosin]] | :C02CA01 [[Prazosin]] | ||
:C02CA02 [[Indoramin]] | :C02CA02 [[Indoramin]] | ||
| Line 46: | Line 46: | ||
:C02CA06 [[Urapidil]] | :C02CA06 [[Urapidil]] | ||
=== | ===<span class="anchor" id="C02CC"></span>C02CC Guanidine derivatives=== | ||
:C02CC01 [[Betanidine]] | :C02CC01 [[Betanidine]] | ||
:C02CC02 [[Guanethidine]] | :C02CC02 [[Guanethidine]] | ||
| Line 55: | Line 55: | ||
:C02CC07 [[Guanoxabenz]] | :C02CC07 [[Guanoxabenz]] | ||
== | ==<span class="anchor" id="C02D"></span>C02D Arteriolar smooth muscle, agents acting on== | ||
=== | ===<span class="anchor" id="C02DA"></span>C02DA Thiazide derivatives=== | ||
:C02DA01 [[Diazoxide]] | :C02DA01 [[Diazoxide]] | ||
=== | ===<span class="anchor" id="C02DB"></span>C02DB Hydrazinophthalazine derivatives=== | ||
:C02DB01 [[Dihydralazine]] | :C02DB01 [[Dihydralazine]] | ||
:C02DB02 [[Hydralazine]] | :C02DB02 [[Hydralazine]] | ||
| Line 66: | Line 66: | ||
:C02DB04 [[Cadralazine]] | :C02DB04 [[Cadralazine]] | ||
=== | ===<span class="anchor" id="C02DC"></span>C02DC Pyrimidine derivatives=== | ||
:C02DC01 [[Minoxidil]] | :C02DC01 [[Minoxidil]] | ||
=== | ===<span class="anchor" id="C02DD"></span>C02DD Nitroferricyanide derivatives=== | ||
:C02DD01 [[Nitroprusside]] | :C02DD01 [[Nitroprusside]] | ||
=== | ===<span class="anchor" id="C02DG"></span>C02DG Guanidine derivatives=== | ||
:C02DG01 [[Pinacidil]] | :C02DG01 [[Pinacidil]] | ||
== | ==<span class="anchor" id="C02K"></span>C02K Other antihypertensives== | ||
=== | ===<span class="anchor" id="C02KA"></span>C02KA Alkaloids, excluding rauwolfia=== | ||
:C02KA01 [[Veratrum]] | :C02KA01 [[Veratrum]] | ||
=== | ===<span class="anchor" id="C02KB"></span>C02KB Tyrosine hydroxylase inhibitors=== | ||
:C02KB01 [[Metirosine]] | :C02KB01 [[Metirosine]] | ||
=== | ===<span class="anchor" id="C02KC"></span>C02KC MAO inhibitors=== | ||
:C02KC01 [[Pargyline]] | :C02KC01 [[Pargyline]] | ||
=== | ===<span class="anchor" id="C02KD"></span>C02KD Serotonin antagonists=== | ||
:C02KD01 [[Ketanserin]] | :C02KD01 [[Ketanserin]] | ||
=== | ===<span class="anchor" id="C02KN"></span>C02KN Other antihypertensives=== | ||
:C02KN01 [[Aprocitentan]] | :C02KN01 [[Aprocitentan]] | ||
:C02KN02 [[Baxdrostat]] | |||
=== | ===<span class="anchor" id="C02KX"></span>C02KX Antihypertensives for pulmonary arterial hypertension=== | ||
:C02KX01 [[Bosentan]] | :C02KX01 [[Bosentan]] | ||
:C02KX02 [[Ambrisentan]] | :C02KX02 [[Ambrisentan]] | ||
| Line 102: | Line 103: | ||
:C02KX54 [[Macitentan/tadalafil|Macitentan and tadalafil]] | :C02KX54 [[Macitentan/tadalafil|Macitentan and tadalafil]] | ||
== | ==<span class="anchor" id="C02L"></span>C02L Antihypertensives and diuretics in combination== | ||
=== | ===<span class="anchor" id="C02LA"></span>C02LA Rauwolfia alkaloids and diuretics in combination=== | ||
:C02LA01 Reserpine and diuretics | :C02LA01 Reserpine and diuretics | ||
:C02LA02 Rescinnamine and diuretics | :C02LA02 Rescinnamine and diuretics | ||
| Line 117: | Line 118: | ||
:C02LA71 Reserpine and diuretics, combinations with [[psycholeptic]]s | :C02LA71 Reserpine and diuretics, combinations with [[psycholeptic]]s | ||
=== | ===<span class="anchor" id="C02LB"></span>C02LB Methyldopa and diuretics in combination=== | ||
:C02LB01 Methyldopa (levorotatory) and diuretics | :C02LB01 Methyldopa (levorotatory) and diuretics | ||
=== | ===<span class="anchor" id="C02LC"></span>C02LC Imidazoline receptor agonists in combination with diuretics=== | ||
:C02LC01 Clonidine and diuretics | :C02LC01 Clonidine and diuretics | ||
:C02LC05 Moxonidine and diuretics | :C02LC05 Moxonidine and diuretics | ||
:C02LC51 Clonidine and diuretics, combinations with other drugs | :C02LC51 Clonidine and diuretics, combinations with other drugs | ||
=== | ===<span class="anchor" id="C02LE"></span>C02LE Alpha-adrenoreceptor antagonists and diuretics=== | ||
:C02LE01 Prazosin and diuretics | :C02LE01 Prazosin and diuretics | ||
=== | ===<span class="anchor" id="C02LF"></span>C02LF Guanidine derivatives and diuretics=== | ||
:C02LF01 Guanethidine and diuretics | :C02LF01 Guanethidine and diuretics | ||
=== | ===<span class="anchor" id="C02LG"></span>C02LG Hydrazinophthalazine derivatives and diuretics=== | ||
:C02LG01 Dihydralazine and diuretics | :C02LG01 Dihydralazine and diuretics | ||
:C02LG02 Hydralazine and diuretics | :C02LG02 Hydralazine and diuretics | ||
| Line 138: | Line 139: | ||
:C02LG73 Picodralazine and diuretics, combinations with psycholeptics | :C02LG73 Picodralazine and diuretics, combinations with psycholeptics | ||
=== | ===<span class="anchor" id="C02LK"></span>C02LK Alkaloids, excluding rauwolfia, in combination with diuretics=== | ||
:C02LK01 Veratrum and diuretics | :C02LK01 Veratrum and diuretics | ||
=== | ===<span class="anchor" id="C02LL"></span>C02LL MAO inhibitors and diuretics=== | ||
:C02LL01 Pargyline and diuretics | :C02LL01 Pargyline and diuretics | ||
=== | ===<span class="anchor" id="C02LN"></span>C02LN Serotonin antagonists and diuretics=== | ||
=== | ===<span class="anchor" id="C02LX"></span>C02LX Other antihypertensives and diuretics=== | ||
:C02LX01 Pinacidil and diuretics | :C02LX01 Pinacidil and diuretics | ||
== | ==<span class="anchor" id="C02N"></span>C02N Combinations of antihypertensives in ATC-group C02== | ||
:''Empty group'' | :''Empty group'' | ||
Latest revision as of 07:13, 23 December 2025
Template:Short description Template:Short descriptionScript error: No such module "Sidebar". ATC code C02 Antihypertensives is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup C02 is part of the anatomical group C Cardiovascular system.[4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QC02.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
C02A Antiadrenergic agents, centrally acting
C02AA Rauvolfia alkaloids
- C02AA01 Rescinnamine
- C02AA02 Reserpine
- C02AA03 Combinations of rauwolfia alkaloids
- C02AA04 Rauwolfia alkaloids, whole root
- C02AA05 Deserpidine
- C02AA06 Methoserpidine
- C02AA07 Bietaserpine
- C02AA52 Reserpine, combinations
- C02AA53 Combinations of rauwolfia alkaloids, combinations
- C02AA57 Bietaserpine, combinations
C02AB Methyldopa
- C02AB01 Methyldopa (levorotatory)
- C02AB02 Methyldopa (racemic)
C02AC Imidazoline receptor agonists
- C02AC01 Clonidine
- C02AC02 Guanfacine
- C02AC04 Tolonidine
- C02AC05 Moxonidine
- C02AC06 Rilmenidine
C02B Antiadrenergic agents, ganglion-blocking
C02BA Sulfonium derivatives
- C02BA01 Trimetaphan
C02BB Secondary and tertiary amines
- C02BB01 Mecamylamine
C02BC Bisquaternary ammonium compounds
C02C Antiadrenergic agents, peripherally acting
C02CA Alpha-adrenoreceptor antagonists
- C02CA01 Prazosin
- C02CA02 Indoramin
- C02CA03 Trimazosin
- C02CA04 Doxazosin
- C02CA06 Urapidil
C02CC Guanidine derivatives
- C02CC01 Betanidine
- C02CC02 Guanethidine
- C02CC03 Guanoxan
- C02CC04 Debrisoquine
- C02CC05 Guanoclor
- C02CC06 Guanazodine
- C02CC07 Guanoxabenz
C02D Arteriolar smooth muscle, agents acting on
C02DA Thiazide derivatives
- C02DA01 Diazoxide
C02DB Hydrazinophthalazine derivatives
- C02DB01 Dihydralazine
- C02DB02 Hydralazine
- C02DB03 Endralazine
- C02DB04 Cadralazine
C02DC Pyrimidine derivatives
- C02DC01 Minoxidil
C02DD Nitroferricyanide derivatives
- C02DD01 Nitroprusside
C02DG Guanidine derivatives
- C02DG01 Pinacidil
C02K Other antihypertensives
C02KA Alkaloids, excluding rauwolfia
- C02KA01 Veratrum
C02KB Tyrosine hydroxylase inhibitors
- C02KB01 Metirosine
C02KC MAO inhibitors
- C02KC01 Pargyline
C02KD Serotonin antagonists
- C02KD01 Ketanserin
C02KN Other antihypertensives
- C02KN01 Aprocitentan
- C02KN02 Baxdrostat
C02KX Antihypertensives for pulmonary arterial hypertension
- C02KX01 Bosentan
- C02KX02 Ambrisentan
- C02KX03 Sitaxentan
- C02KX04 Macitentan
- C02KX05 Riociguat
- C02KX06 Sotatercept
- C02KX52 Ambrisentan and tadalafil
- C02KX54 Macitentan and tadalafil
C02L Antihypertensives and diuretics in combination
C02LA Rauwolfia alkaloids and diuretics in combination
- C02LA01 Reserpine and diuretics
- C02LA02 Rescinnamine and diuretics
- C02LA03 Deserpidine and diuretics
- C02LA04 Methoserpidine and diuretics
- C02LA07 Bietaserpine and diuretics
- C02LA08 Rauwolfia alkaloids, whole root and diuretics
- C02LA09 Syrosingopine and diuretics
- C02LA50 Combinations of rauwolfia alkaloids and diuretics including other combinations
- C02LA51 Reserpine and diuretics, combinations with other drugs
- C02LA52 Rescinnamine and diuretics, combinations with other drugs
- C02LA71 Reserpine and diuretics, combinations with psycholeptics
C02LB Methyldopa and diuretics in combination
- C02LB01 Methyldopa (levorotatory) and diuretics
C02LC Imidazoline receptor agonists in combination with diuretics
- C02LC01 Clonidine and diuretics
- C02LC05 Moxonidine and diuretics
- C02LC51 Clonidine and diuretics, combinations with other drugs
C02LE Alpha-adrenoreceptor antagonists and diuretics
- C02LE01 Prazosin and diuretics
C02LF Guanidine derivatives and diuretics
- C02LF01 Guanethidine and diuretics
C02LG Hydrazinophthalazine derivatives and diuretics
- C02LG01 Dihydralazine and diuretics
- C02LG02 Hydralazine and diuretics
- C02LG03 Picodralazine and diuretics
- C02LG51 Dihydralazine and diuretics, combinations with other drugs
- C02LG73 Picodralazine and diuretics, combinations with psycholeptics
C02LK Alkaloids, excluding rauwolfia, in combination with diuretics
- C02LK01 Veratrum and diuretics
C02LL MAO inhibitors and diuretics
- C02LL01 Pargyline and diuretics
C02LN Serotonin antagonists and diuretics
C02LX Other antihypertensives and diuretics
- C02LX01 Pinacidil and diuretics
C02N Combinations of antihypertensives in ATC-group C02
- Empty group
References
<templatestyles src="Reflist/styles.css" />
Script error: No such module "Check for unknown parameters".
Script error: No such module "Navbox". Script error: No such module "Navbox".